Nasdaq-, New York, listed company ASP Isotopes (ASPI), which has its head office in Washington, DC, but most of its operations in South Africa, has announced its intention, assuming the granting of the necessary regulatory approvals, to list on the Main Board of the JSE, later this year. ASPI was an isotope enrichment technology and processes development and manufacturing company, that had its roots in South Africa. "While our investor base has been created in the USA and Europe, the beating heart of our company is clearly currently in South Africa, with 97% of our employees and all our operating assets being located in South Africa," explained ASPI Chairperson and CEO Paul Mann. "We have to thank our South African staff, service providers and regulators for helping us to achieve all we have done over the last four years and therefore we owe it to South Africa to make our securities available to the local community."